Depression derives from activation of immune-inflammatory pathways, according to that the release of IL-1β and TNF-α triggers off neuroendocrine and neurochemical deterioration (Dowlati et al., 2010; Shelton et al., 2011; Hiles et al., 2012; Zhao et al., 2017). Here, IL1B is linked to depressive symptom measurement.